• Kyodo

  • SHARE

Researchers have developed a method to assess the risk of breast or ovarian cancer through genetic checking that is 10 times cheaper than the current way, a Japanese scientific institute says.

The team, led by Itsuro Inoue, a professor at the National Institute of Genetics, said it has filed a patent for the new method, which could bring the cost, currently around ¥200,000 to ¥300,000 per person, down to about ¥20,000.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW